Shopping Cart
- Remove All
- Your shopping cart is currently empty
TRPC3/6-IN-1 is a highly potent and selective inhibitor that blocks the activity of canonical transient receptor channels TRPC3 and TRPC6, showing significant potency against human isoforms hTRPC3 and hTRPC6 with IC50 values of 1260 nM and 500 nM, respectively. This compound is valuable for research on chronic models of heart failure [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $83 | 35 days | |
5 mg | $268 | 35 days | |
10 mg | $450 | 35 days | |
25 mg | $918 | 35 days |
Description | TRPC3/6-IN-1 is a highly potent and selective inhibitor that blocks the activity of canonical transient receptor channels TRPC3 and TRPC6, showing significant potency against human isoforms hTRPC3 and hTRPC6 with IC50 values of 1260 nM and 500 nM, respectively. This compound is valuable for research on chronic models of heart failure [1]. |
In vitro | TRPC3/6-IN-1 exhibits blocking activity against hTRPC3 and hTRPC6, achieving half-maximal inhibitory concentrations (IC50) of 1260 nM and 500 nM, respectively [1]. |
In vivo | TRPC3/6-IN-1 (compound 3) exhibits favorable pharmacokinetics in rats. At an intravenous dose of 0.93 mg/kg, it reaches a Cmax of 250 ng/ml with a clearance rate of 120 ml/min/kg. The MRT is 0.3 hours and the DNAUC is 0.14 h kg/L, indicating an oral bioavailability (~F) of approximately 1%. |
Molecular Weight | 365.45 |
Formula | C20H19N3O2S |
Cas No. | 736945-96-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.